Membranoproliferative GN (MPGN) was recently reclassified as alternative pathway complement–mediated C3 glomerulopathy (C3G) and immune complex–mediated membranoproliferative GN (IC-MPGN). However, genetic and acquired alternative pathway abnormalities are also observed in IC-MPGN. Here, we explored the presence of distinct disease entities characterized by specific pathophysiologic mechanisms. We performed unsupervised hierarchical clustering, a data-driven statistical approach, on histologic, genetic, and clinical data and data regarding serum/plasma complement parameters from 173 patients with C3G/IC-MPGN. This approach divided patients into four clusters, indicating the existence of four different pathogenetic patterns. Specifically, this analysis separated patients with fluid-phase complement activation (clusters 1–3) who had low serum C3 levels and a high prevalence of genetic and acquired alternative pathway abnormalities from patients with solid-phase complement activation (cluster 4) who had normal or mildly altered serum C3, late disease onset, and poor renal survival. In patients with fluid-phase complement activation, those in clusters 1 and 2 had massive activation of the alternative pathway, including activation of the terminal pathway, and the highest prevalence of subendothelial deposits, but those in cluster 2 had additional activation of the classic pathway and the highest prevalence of nephrotic syndrome at disease onset. Patients in cluster 3 had prevalent activation of C3 convertase and highly electron-dense intramembranous deposits. In addition, we provide a simple algorithm to assign patients with C3G/IC-MPGN to specific clusters. These distinct clusters may facilitate clarification of disease etiology, improve risk assessment for ESRD, and pave the way for personalized treatment.

Iatropoulos, P., Daina, E., Curreri, M., Piras, R., Valoti, E., Mele, C., et al. (2018). Cluster analysis identifies distinct pathogenetic patterns in c3 glomerulopathies/immune complex–Mediated membranoproliferative GN. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 29(1), 283-294 [10.1681/ASN.2017030258].

Cluster analysis identifies distinct pathogenetic patterns in c3 glomerulopathies/immune complex–Mediated membranoproliferative GN

Sinico, R. A.;
2018

Abstract

Membranoproliferative GN (MPGN) was recently reclassified as alternative pathway complement–mediated C3 glomerulopathy (C3G) and immune complex–mediated membranoproliferative GN (IC-MPGN). However, genetic and acquired alternative pathway abnormalities are also observed in IC-MPGN. Here, we explored the presence of distinct disease entities characterized by specific pathophysiologic mechanisms. We performed unsupervised hierarchical clustering, a data-driven statistical approach, on histologic, genetic, and clinical data and data regarding serum/plasma complement parameters from 173 patients with C3G/IC-MPGN. This approach divided patients into four clusters, indicating the existence of four different pathogenetic patterns. Specifically, this analysis separated patients with fluid-phase complement activation (clusters 1–3) who had low serum C3 levels and a high prevalence of genetic and acquired alternative pathway abnormalities from patients with solid-phase complement activation (cluster 4) who had normal or mildly altered serum C3, late disease onset, and poor renal survival. In patients with fluid-phase complement activation, those in clusters 1 and 2 had massive activation of the alternative pathway, including activation of the terminal pathway, and the highest prevalence of subendothelial deposits, but those in cluster 2 had additional activation of the classic pathway and the highest prevalence of nephrotic syndrome at disease onset. Patients in cluster 3 had prevalent activation of C3 convertase and highly electron-dense intramembranous deposits. In addition, we provide a simple algorithm to assign patients with C3G/IC-MPGN to specific clusters. These distinct clusters may facilitate clarification of disease etiology, improve risk assessment for ESRD, and pave the way for personalized treatment.
Articolo in rivista - Articolo scientifico
C3 glomerulonephritis; C3 glomerulopathy; Complement system; Dense Deposit Disease; Rare diseases; membranoproliferative glomerulonephritis (MPGN); Nephrology
English
283
294
12
Iatropoulos, P., Daina, E., Curreri, M., Piras, R., Valoti, E., Mele, C., et al. (2018). Cluster analysis identifies distinct pathogenetic patterns in c3 glomerulopathies/immune complex–Mediated membranoproliferative GN. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 29(1), 283-294 [10.1681/ASN.2017030258].
Iatropoulos, P; Daina, E; Curreri, M; Piras, R; Valoti, E; Mele, C; Bresin, E; Gamba, S; Alberti, M; Breno, M; Perna, A; Bettoni, S; Sabadini, E; Murer, L; Vivarelli, M; Noris, M; Remuzzi, G; Bottanelli, L; Donadelli, R; Cuccarolo, P; Abbate, M; Carrara, C; Cannata, A; Ferrari, S; Gaspari, F; Stucchi, N; Bassani, C; Lena, M; Omati, G; Taruscia, D; Bellantuono, R; Giordano, M; Messina, G; Caruso, M; Gotti, E; Mescia, F; Perticucci, E; Schieppati, A; Verdoni, L; Berto, M; Baraldi, O; Montini, G; Pasini, A; Passler, W; Degasperi, T; Gaggiotti, M; Gregorini, G; Miglietti, N; Guarnieri, A; Cirami, L; Roperto, R; Di Giorgio, G; Barbano, G; Innocenti, M; Ghiggeri, G; Magnasco, A; Rolla, D; Casartelli, D; Lambertini, D; Maggio, M; Cosci, P; Conti, G; Amar, K; Ardissino, G; Marinosci, A; Sinico, R; Montoli, A; Bonucchi, D; Facchini, F; Furci, L; Ferretti, A; Nuzzi, F; Pecoraro, C; Visciano, B; Canavese, C; Radin, E; Stratta, P; Nordio, M; Benetti, E; Parolin, M; Alberici, F; Manenti, L; Brugnano, R; Manenti, F; Capitanini, A; Emma, F; Massella, L; Rosa, M; Mazzon, M; Basso, E; Besso, L; Lavacca, A; Mella, A; Bertero, M; Coppo, R; Peruzzi, L; Porcellini, M; Piccoli, G; Clari, R; Pasi, A; Gangemi, C; Alfandary, H; Dagan, A; Conceiçao, M; Sameiro, F; Croze, L; Malvezzi, P; Tsygin, A; Zelan, B; Nastasi, N
File in questo prodotto:
File Dimensione Formato  
10281-230586.pdf

accesso aperto

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 1.47 MB
Formato Adobe PDF
1.47 MB Adobe PDF Visualizza/Apri
Cluster analysis.....pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 3.27 MB
Formato Adobe PDF
3.27 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/230586
Citazioni
  • Scopus 55
  • ???jsp.display-item.citation.isi??? 54
Social impact